31
Jan
2022
Tag: drug development
17
Jan
2022
Bionest
Novartis and UK NHS Collaborate for Targeted Access to Levqio
Novartis is teaming up with the NHS to make the PCSK9 inhibitor Leqvio available for UK heart patients who struggle to control their LDL cholesterol with existing drugs.
27
Dec
2021
Bionest
Addressing Gene Therapy UncertaintiesÂ
Are we close to more streamlined and standardized approaches to gene therapy testing and regulations?
13
Dec
2021
Bionest
UK Policy Changes Allow Earlier Access to Innovative Medicines for Rare Diseases
Access to new treatments for rare diseases in the UK has often been a challenge. Will a new decision-making framework & funding improve the situation?
15
Nov
2021
Bionest
Protein Folding Determination Makes Gigantic Leap Forward
Will a new ability to rapidly decipher protein folding and picture protein structures open up new research avenues with applications in pharma R&D?
21
Sep
2020
Bionest
Look Beyond the US and Europe for Rare Disease Launches
Rest-of-world markets offer good opportunities for rare disease companies to expand their sales potential beyond what U.S. & E.U. markets offer, and the requirements for market entry should be considered at a high level early on.
25
May
2020
Bionest
Coronavirus Impacts on Industry: Part 1
As the COVID-19 pandemic rages on, the effects of the virus are being felt not only by the global populace, but by the various sectors of the health care industry and those that support them.
13
Apr
2020
Bionest
FDA Finalizes Gene Therapy Guidelines and Adds New Draft Guidance on Orphan Drug Exclusivity
The field of gene and cell therapy is flourishing. How is the FDA responding?
30
Mar
2020
Bionest
New Research Findings — and Potential New Avenues for Drug Discovery — in Type 2 Diabetes
Could two proteins -- TRAP-alpha and adipsin -- provide new ways to treat diabetes?
2
Mar
2020